Krishna Institute of Medical Sciences approves QIP issue opening and floor price
Krishna Institute of Medical Sciences · Healthcare Services
Key highlights
- Finance & Investment Committee approved preliminary placement document and opening of QIP issue on 16th June 2026
- Floor price fixed at ₹771.73 per Equity Share based on SEBI ICDR Regulations, with a potential 5% discount
- Relevant Date for pricing is 16th June 2026; members approved the issue via special resolution on 15th April 2026
Why it's rated notable: The filing opens a QIP and sets a floor price of ₹ 771.73 per Equity Share, but states no issue size and the issue price is yet to be determined, so the level stays at medium.
Original filing
The Finance & Investment Committee Has, At Its Meeting Held Today, I.E., 16Th June, 2026, Inter-Alia, Considered And Approved The Following: (A) Approval And Adoption Of The Preliminary Placement Document Dated 16Th June, 2026 Together With The Application Form In Connection With The Issue; (B) Approval And Authorisation Of The Opening Of The Issue Today, I.E., 16Th June, 2026 And (C) Approved The Floor Price For The Issue As Prescribed Under SEBI ICDR Regulations, Being ? 771.73 Per Equit
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Krishna Institute of Medical Sciences
- Acquisition / mergerNotableKrishna Institute of Medical Sciences approves Q2 financials and key reappointments
- Financial resultsNotableKrishna Institute of Medical Sciences Ltd announces Q2 results and key appointments
- Acquisition / mergerNotableKIMS announces acquisition of up to 51% stake in Insignia Healthcare Pvt Ltd
- Fundraise / allotmentNotableKrishna Institute of Medical Sciences receives NSE and BSE in-principle approval for warrant issue
- Financial resultsMajor development· Adverse for the businessKrishna Institute of Medical Sciences approves unaudited Q1 consolidated results
Other fundraise / allotment filings this fortnight
- Supreme Engineering allots 14,50,00,000 warrants at ₹2.60 on preferential basis
- Bajaj Finance Limited allots 5.74 crore warrants to Bajaj Finserv on 10 Nov 2026
- Bajaj Finance approves preferential issue of 5.74 crore warrants to Bajaj Finserv
- Chaman Metallics Limited announces H1 FY27 financial results and proposed Rights Issue
- Harmony Capital Services receives BSE approval for preferential issue of shares
- Kuber Udyog: open offer corrigendum, allotments of shares and warrants at ₹23.10
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM QualityGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.